Close Menu

NEW YORK – Natera said on Monday that it has sued ArcherDx, alleging infringement of a recently issued patent covering target amplification.

In its complaint, filed with the US District Court of Delaware, San Carlos, California-based Natera said that ArcherDx, based in Boulder, Colorado, infringes its US Patent No. 10,538,814 titled "Methods for Simultaneous Amplification of Target Loci." The patent, issued on Jan. 21, covers methods that use multiplex PCR to amplify several nucleic acid regions in the same reaction for sequencing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.